Invivo therapeutics announces appointment of heather m. hamel as chief legal officer and general counsel

Cambridge, mass.--(business wire)--invivo therapeutics holdings corp. (nasdaq: nviv), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced the appointment of heather m. hamel, j.d. as its chief legal officer and general counsel. in her role, ms. hamel will lead the company's legal and intellectual property functions, and provide strategic guidance to the company's board of directors and executive management t
NVIV Ratings Summary
NVIV Quant Ranking